Xianzhi Mao

Title: Xianzhi Mao: Innovator in Human Receptor Tyrosine Kinase

Introduction

Xianzhi Mao is a notable inventor based in Rockledge, PA (US). He has made significant contributions to the field of biotechnology, particularly in the area of human receptor tyrosine kinases. With a total of 4 patents to his name, Mao's work has advanced our understanding of these critical proteins.

Latest Patents

Mao's latest patents include a groundbreaking discovery related to the human receptor tyrosine kinase, KDR. This patent discloses an isolated nucleic acid molecule encoding a novel human receptor type tyrosine kinase gene, KDR. The isolation of this KDR cDNA sequence has led to the disclosure of purified forms of human KDR protein, recombinant vectors, and recombinant hosts that express human KDR. This innovation holds promise for various applications in medical research and therapeutic development.

Career Highlights

Xianzhi Mao is currently employed at Merck & Company, Inc., where he continues to push the boundaries of scientific research. His work at Merck has allowed him to collaborate with some of the brightest minds in the industry, further enhancing his contributions to the field.

Collaborations

Some of Mao's notable coworkers include Richard L. Kendall and Kenneth A. Thomas, Jr. Their collaborative efforts have fostered an environment of innovation and discovery, leading to advancements in biotechnology.

Conclusion

Xianzhi Mao's contributions to the field of human receptor tyrosine kinases exemplify the impact of dedicated inventors in advancing scientific knowledge. His work not only enhances our understanding of these proteins but also paves the way for future innovations in biotechnology.